Gillian Cannon
Directeur/Membre du Conseil chez CORCEPT THERAPEUTICS INCORPORATED
Fortune : - $ au 30/04/2024
Profil
Gillian M.
Cannon is currently serving as an Independent Director at Corcept Therapeutics, Inc., Director at Affibody AB, Director at Xenon Pharmaceuticals, Inc., Director at Edinburgh Innovations Ltd., and Head-Commercial Innovation at Roivant Sciences, Inc. She is also the President of Alyvant, Inc. Dr. Cannon has previously worked as the President-North American Operations at UCB, Inc. and Vice President-Commercial Operations at Merck BioVentures.
She has an undergraduate degree from The University of Edinburgh and doctorate degrees from Temple University (Pennsylvania) and Fox School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/08/2023 | 0 ( -.--% ) | - $ | 30/04/2024 | |
| 05/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Gillian Cannon
| Sociétés | Poste | Début |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 23/11/2020 |
| XENON PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 08/08/2023 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/01/2019 |
| Alyvant, Inc. | President | 01/01/2018 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2020 |
Edinburgh Innovations Ltd.
 Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de Gillian Cannon
| Sociétés | Poste | Fin |
|---|---|---|
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Corporate Officer/Principal | 01/01/2017 |
| Merck BioVentures | Corporate Officer/Principal | 01/01/2012 |
Formation de Gillian Cannon
| Fox School of Business | Doctorate Degree |
| The University of Edinburgh | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Merck BioVentures | |
| Alyvant, Inc. | |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Edinburgh Innovations Ltd.
Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Commercial Services |